Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Surveyed physicians up for hybrid healthcare, down on Medicare for All

U.S. physicians favor the idea of a two-tiered healthcare system, one in which a single-payer option peacefully coexists with private coverage. Their least favorite model? Single-payer Medicare for All.

Nearly all nursing homes are hurting, but should the for-profits get more free money?

Even after receiving $7.5 billion in federal COVID relief and billions more from the Paycheck Protection Program, nursing homes are still hurting financially. Should the field’s for-profit players have their hands out with the rest?

Thumbnail

Advocates applaud legislation that would improve coverage for peripheral artery disease screening

If signed into law, the bill would improve coverage for screening for both Medicare and Medicaid beneficiaries. 

Thumbnail

CMS will delay start of radiation oncology payment model until July

The American Society for Radiation Oncology said it is "pleased" and "thankful" the federal agency listened to the needs of physician practices.

start date 2021 track calendar

CMS delays radiation oncology payment model following fierce opposition from physician community

The American College of Radiology had expressed "alarm" over a Jan. 1 launch date, concerned CMS was rushing the rollout and including too many small practices. 

District of Columbia DC congress capitol hill

Physician lawmakers intensify pressure to avert millions in Medicare cuts to radiology

House members called the matter “of great urgency,” highlighting substantial cuts set to hit the Medicare Physician Fee Schedule Jan. 1. 

Thumbnail

Radiologist Scott Atlas’ ‘junk science’ takes White House center stage to dismay of Fauci, others

That’s according to a high-profile report based on interviews with dozens of administration officials. 

Brit study: Money-motivated parties weighed in heavily on FDA’s medical AI regulation

Of 125 public comments submitted to the FDA on how best to regulate AI software as a medical device, nearly two-thirds came from parties with financial ties to industry, according to a study running in BMJ Open.